Bank of New York Mellon
RCEL icon

Bank of New York Mellon’s Avita Medical RCEL Stock Holding History

Bank of New York Mellon’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-29,863
Closed -$110K – 4405
2026
Q1 		$110K Buy
29,863
+1
+0% +$4 ﹤0.01% 4091
2025
Q4 		$103K Sell
29,862
-1,130
-4% -$4.51K ﹤0.01% 4103
2025
Q3 		$158K Sell
30,992
-24,259
-44% -$127K ﹤0.01% 4062
2025
Q2 		$292K Buy
55,251
+110
+0.2% +$800 ﹤0.01% 3816
2025
Q1 		$449K Buy
55,141
+1,924
+4% +$18K ﹤0.01% 3503
2024
Q4 		$681K Buy
53,217
+114
+0.2% +$1.34K ﹤0.01% 3363
2024
Q3 		$569K Sell
53,103
-19,586
-27% -$184K ﹤0.01% 3443
2024
Q2 		$576K Sell
72,689
-34,919
-32% -$332K ﹤0.01% 3505
2024
Q1 		$1.72M Sell
107,608
-9,070
-8% -$147K ﹤0.01% 2840
2023
Q4 		$1.6M Sell
116,678
-11,094
-9% -$127K ﹤0.01% 2944
2023
Q3 		$1.87M Buy
127,772
+11,571
+10% +$196K ﹤0.01% 2849
2023
Q2 		$1.98M Buy
116,201
+59,505
+105% +$873K ﹤0.01% 2845
2023
Q1 		$792K Buy
56,696
+160
+0.3% +$1.7K ﹤0.01% 3239
2022
Q4 		$373K Hold
56,536
– – ﹤0.01% 3695
2022
Q3 		$298K Hold
56,536
– – ﹤0.01% 3840
2022
Q2 		$269K Sell
56,536
-49,832
-47% -$308K ﹤0.01% 3938
2022
Q1 		$902K Buy
106,368
+33,375
+46% +$308K ﹤0.01% 3375
2021
Q4 		$874K Buy
72,993
+1,535
+2% +$23.4K ﹤0.01% 3459
2021
Q3 		$1.27M Buy
71,458
+11,024
+18% +$208K ﹤0.01% 3262
2021
Q2 		$1.24M Buy
60,434
+48,628
+412% +$958K ﹤0.01% 3279
2021
Q1 		$234K Sell
11,806
-1,216
-9% -$28.3K ﹤0.01% 4004
2020
Q4 		$242K Buy
13,022
+3,774
+41% +$82.8K ﹤0.01% 3914
2020
Q3 		$233K Buy
+9,248
New +$231K ﹤0.01% 3795

Other funds holding RCEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
RS
R Squared Central, Hong Kong $190M AUM 25.89% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return
NC
nVerses Capital Wellington, Florida $65M AUM
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

Bank of New York Mellon's RCEL Position: Q2 2026 in Review

Bank of New York Mellon sold out of Avita Medical (RCEL) in Q2 2026, closing a stake of 29,863 shares — an estimated $110K sold.

Bank of New York Mellon first reported a position in RCEL in Q3 2020 and held it in 23 quarters. The position peaked at $1.98M in Q2 2023. 27 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • Bank of New York Mellon reported no remaining Avita Medical position as of Q2 2026 after selling out during the quarter.
  • Bank of New York Mellon sold 29,863 Avita Medical shares in Q2 2026, an estimated $110K.
  • Bank of New York Mellon first reported a position in Avita Medical in Q3 2020 and held it in 23 quarters.
  • Bank of New York Mellon's Avita Medical position peaked at $1.98M in Q2 2023.
  • 27 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.